Neurochemicals | Signal Transduction Agents | Peptides | Biochemicals
Tocris Bioscience : www.tocris.com
Tocris Bioscience : www.tocris.com High Performance Life Science Reagents

New Products for November 2009

Potent and selective CB1 agonist
3676 | PF 514273

Ki values are 1 and > 10000 nM at CB1 and CB2 receptors respectively. Inhibits food intake in vivo following oral administration.

Related Products: AM 251 LY 320135 O-2050
Selective FGFR1 and -3 inhibitor
3044 | PD 173074

IC50 values are 5, 21.5, ~100, 17600 and 19800 nM for FGFR3, FGFR1, VEGFR2, PDGFR and c-Src respectively. Inhibits VEGF- and FGF-induced angiogenesis in the mouse cornea model of angiogenesis.

Related Products: SU 5402 SU 6668
Selective D2-like agonist
3680 | Ropinirole

D3 > D2 > D4. Causes biphasic spontaneous locomotor activity and contralateral circling in 6-OHDA-lesioned mice. Displays antiParkinsonian activity.

Related Products: (-)-Quinpirole Bromocriptine (S)-(-)-Sulpiride
Benzodiazepine agonist
3655 | Zaleplon

Non-benzodiazepine agent that acts as an agonist at the benzodiazepine site. Displays hypnotic, anxiolytic, myorelaxant and anticonvulsant activity.

Related Products: L-655,708 Zolpidem Zopiclone
Dual site Src kinase inhibitor
3642 | Src I1

IC50 values are 44 and 88 nM for Src and Lck respectively. Can be used in parallel with PP 1 and PP 2 to inhibit Src family kinases.

Related Products: Piceatannol PP 2 PP 1
All new products this month :

Allopregnanolone, BIX 01294, Carcinine, CITCO, GRK2i, (-)-Indolactam V, Lys-γ3-MSH, Neuromedin S (rat), Neuropeptide SF (mouse, rat), N-Nonyldeoxynojirimycin, NXY 059, Parstatin (mouse), PD 173074, 4,4-Pentamethylenepiperidine, PF 514273, Pregnanolone, PRIMA-1MET, Ropinirole, RuBi-4AP, RuBi-Glutamate, Serotonin, Src I1, Zaleplon


Sign-up for new products e-alerts.

© Copyright 2009 Tocris Bioscience All rights reserved

www.tocris.com | Search for Products | Request Catalog | Contact Us

Depression Poster
Written by P. Skolnich et al :

Depression Poster

'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.

Tocris Events
Meet your representative:

Visit your Tocris representative at the AHA Scientific Sessions in Orlando.

AHA Scientific Sessions 2009
15 - 17th November, 2009
Orlando, Florida
Booth No. 1903

Visit your Tocris representative at the ASCB conference in San Diego

ASCB Annual Meeting 2009
5 - 9th December, 2009
San Diego, CA
Booth No. 1250